Sep. 5, 2019: An extra decade of "heart age"; stop grouping trans women with MSM; women often have anal cancer precursor lesions; hep C treatment success doesn't equal more risk behavior.
Communities Should Be Involved in Research. Here Are Some Key Insights on Good Participatory Practice.
Increasingly, researchers are looking for ways to involve communities not just by participating in trials, but by helping shape these projects. But, how do you go about making sure affected communities are at the table?
Asa Radix, M.D., M.P.H., discusses providing quality care to transgender people. It can be done.
"We have never been silent, but you have not heard us": Advocates demonstrate to demand inclusion of indigenous issues in the HIV response.
Four recent studies in JAIDS chiefly focused on PrEP provision to cisgender women and gay and bisexual men.
Plans to expand the program to the entire state are underway.
Primary care providers need more education when it comes to PrEP, not only for them, but also for patients, who often think they need to see a specialist just to take this preventative medicine.
The ECHO trial faces backlash and criticism.
Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa
ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.
July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.